General Information
Product name
Mitomycin C
CAS No.
50-07-7
1.2.1 Relevant identified uses
This products are for laboratory research use only and are not intended for human or animal diagnostics, therapeutics or other clinical uses
Icons in SDS
Company Information
company name
Genaxxon bioscience GmbH
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H351
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
CLP CLASSIFICATION
GHS08 health hazard Carc. 2 H351 Suspected of causing cancer GHS07 Acute Tox. 4 H302 Harmful if swallowed
EU Classification
Directive 67/548 ‘EEC or Directive 1999-45-EC T+: Toxic R28: Toxic if swallowed Xn: Harmful R40: Limited evidence of a carcinogenic effect Information concerning particular hazards for human and environment The product has to be labelled due to the calculation procedure of the “General Classification guideline for preparations of the EU” in the latest version.
Classification system
The classification is according to the latest editions of the EU-lists, and extended by company and literature data. Responsible : CEO Replaces version dated : Print date 2014-12-07– last safed 2014-12-07 1 of 7
2.2 Label elements
Labelling according Regulation (EC) No 1272/2008 The product is classified and labelled according to the CLP regulation.
Hazard pictograms
GHS08 GHS07
Signal word
Warning
Hazard statements
H302 Harmful if swallowed H351 Suspected of causing cancer
Precautionary statements
P281 Use personal protective equipment as required P308 + P313 IF exposed or concerned: Get medical advice/attention.
2.3 Other hazards
none
PBT Substances
Not applicable
vPvB Substances
Not applicable
